MEI Pharma Inc Cash Flow Quality Index
MEI Pharma Inc cash flow quality index. MEI Pharma Inc (MEIP) has a Cash Flow Quality Index of -0.33x as of September 2023. Operating cash flow of $-18.49 Million is below net income of $56.37 Million, suggesting accrual-heavy earnings not yet converted to cash. See MEI Pharma Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of MEI Pharma Inc (2017–2024)
Cash flow quality index of MEI Pharma Inc from 2017 to 2024. Historical Cash Flow Quality Index for MEI Pharma Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore MEI Pharma Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
MEI Pharma Inc Cash Flow Quality Index by Year (2017–2024)
MEI Pharma Inc cash flow quality index by year from 2017 to 2024. Year-by-year earnings quality comparison for MEI Pharma Inc. For the full cash flow conversion analysis, see cash flow conversion of MEI Pharma Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -2.84x | $-50.47 Million | $17.78 Million | ▼ -317.5% |
| 2017 | 1.31x | $3.49 Million | $2.67 Million | — |